Pharmacogenetics: Not Quite Ready for Prime Time?
The Carlat Child Psychiatry Report, Volume 12, Number 1&2, March 2021
https://www.thecarlatreport.com/newsletter-issue/ccprv12n12/
Issue Links: Learning Objectives | Editorial Information
Topics: Chromosomal Microarray | CYP2C19 | CYP2D6 | Fragile X | Genetic Testing | MTHFR | Pharmacogenomics | Whole Genome Sequencing
Aaron Besterman, MD
Child & adolescent psychiatrist at the Rady Children’s Hospital inpatient child and adolescent unit, San Diego, CA.
Dr. Besterman has disclosed that he has no relevant financial or other interests in any commercial companies pertaining to this educational activity.
Genetic testing can tell whether a patient has an identifiable disorder, offering relief to families searching for answers and perhaps leading them to support and even future treatment. Despite the hype, pharmacogenetics is rather limited in utility and clinicians need to know what it can and cannot tell us.
You can't view details of this content, please login or buy subscription here